Author

Ran Meng

Second Affiliated Hospital of Zhejiang UniversityPrimary ORCID profile (0000-0003-1271-3975 · 4 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ran MengiD4 papers · Yale University

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chunfeng He· 1 shared Chunxiao ChengiD· 1 shared Dan ZhouiD· 1 shared Eric R. GamazoniD· 1 shared Jiayao Fan· 1 shared Lang WuiD· 1 shared Ravi V. ShahiD· 1 shared Ruiyuan Pan· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Chunfeng He

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrating population-level and cell-based signatures for drug repositioning

Chunfeng He, Yue Xu, Yuan Zhou, Jiayao Fan, Chunxiao Cheng, Ran Meng, Lang Wu, Ruiyuan Pan, Ravi V. Shah, Eric R. Gamazon, Dan Zhou

This paper introduces TReD, a framework integrating population-level disease signatures and cell-based drug responses to identify potential therapeutics for COVID-19 and T2D.

Bioinformatics · Sep 9, 2025Peer-reviewedBioinformatics